Effects of neonatal naltrindole treatment on antinociceptive and behavioral responses to mu and kappa agonists in rats (Q42691902)

4 November 2017

title

Effects of neonatal naltrindole treatment on antinociceptive and behavioral responses to mu and kappa agonists in rats (English)

1 reference

4 November 2017

B Fernández

1

1 reference

4 November 2017

M T Antelo

series ordinal

2

1 reference

4 November 2017

I Kitchen

series ordinal

3

1 reference

4 November 2017

M P Viveros

series ordinal

4

1 reference

4 November 2017

language of work or name

English

0 references

publication date

1 January 1999

1 reference

Pharmacology, Biochemistry and Behavior

4 November 2017

published in

1 reference

4 November 2017

volume

62

1 reference

4 November 2017

issue

1

1 reference

4 November 2017

page(s)

145-149

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2898%2900138-5

4 November 2017

1 reference

7 January 2021

Effects of the delta-opioid receptor antagonist naltrindole on antinociceptive responses to selective delta-agonists in post-weanling rats

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2898%2900138-5

7 January 2021

Effects of beta-funaltrexamine treatment and sexual isolation in the perinatal period on the development of mu-opioid receptors and nociception

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2898%2900138-5

7 January 2021

Involvement of delta- and mu-opioid receptors in the potentiation of brain-stimulation reward

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2898%2900138-5

7 January 2021

Deltorphins: a family of naturally occurring peptides with high affinity and selectivity for delta opioid binding sites

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2898%2900138-5

7 January 2021

Modulation of mu-mediated antinociception by delta agonists in the mouse: selective potentiation of morphine and normorphine by [D-Pen2,D-Pen5]enkephalin

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2898%2900138-5

7 January 2021

CI-977, a novel and selective agonist for the kappa-opioid receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2898%2900138-5

7 January 2021

An observational analysis of the effect of the selective kappa opioid agonist, U-50,488H, on feeding and related behaviours in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2898%2900138-5

7 January 2021

Behavioural effects of selective mu-, kappa-, and delta-opioid agonists in neonatal rats

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2898%2900138-5

7 January 2021

Low-level lead exposure alters morphine antinociception in neonatal rats

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2898%2900138-5

7 January 2021

Analysis of the antinociceptive actions of the kappa-opioid agonist enadoline (CI-977) in neonatal and adult rats: comparison to kappa-opioid receptor mRNA ontogeny

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2898%2900138-5

7 January 2021

Interaction between the mu-agonist dermorphin and the delta-agonist [D-Ala2, Glu4]deltorphin in supraspinal antinociception and delta-opioid receptor binding

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2898%2900138-5

7 January 2021

Naltrindole, a highly selective and potent non-peptide delta opioid receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2898%2900138-5

7 January 2021

A developmental study on stress-induced antinociception measured by the tail electric stimulation test.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2898%2900138-5

7 January 2021

Prenatal exposure to morphine alters brain mu opioid receptor characteristics in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2898%2900138-5

7 January 2021

Chronic administration of morphine and naltrexone up-regulate mu-opioid binding sites labeled by [3H][D-Ala2,MePhe4,Gly-ol5]enkephalin: further evidence for two mu-binding sites

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2898%2900138-5

7 January 2021

Spinal kappa-opioid receptor-mediated antinociception is stimulus-specific

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2898%2900138-5

7 January 2021

Methodological considerations in neurobehavioral teratology

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2898%2900138-5

7 January 2021

Effect of naltrindole on the development of physical dependence on morphine in mice: A behavioral and biochemical study

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2898%2900138-5

7 January 2021

Selective Natrexone-Derived Opioid Receptor Antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2898%2900138-5

7 January 2021

Morphine-induced downregulation of μ-opioid receptors in neonatal rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2898%2900138-5

7 January 2021

Genetic control of hippocampal cholinergic and dynorphinergic mechanisms regulating novelty-induced exploratory behavior in house mice

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2898%2900138-5

7 January 2021

Behavioral effects of kappa-opioid-receptor stimulation on neonatal rats

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2898%2900138-5

7 January 2021

10.1016/S0091-3057(98)00138-5

Identifiers

DOI

1 reference

4 November 2017

1 reference